[Asia Economy Reporter Kwon Jae-hee] JW Life Science announced on the 10th that its operating profit for the second quarter was tentatively estimated at 7.173 billion KRW. This represents a 1.37% increase compared to the same period last year.



Sales revenue amounted to 46.289 billion KRW, an increase of 12.22% during the same period. Net profit rose by 52.09% to 4.082 billion KRW.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing